The design and synthesis of inhibitors of the cysteinyl protease, Der p I

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 9, 1998, Pages 993-998

  Billson, Jeremy ^a   Clark, Jonathan ^a   Conway, Simon P ^a   Hart, Terance ^a   Johnson, Tony ^a   Langston, Steven P ^a   Ramjee, Manoj ^a   Quibell, Martin ^a   Scott, Richard K ^a  

^a Peptide Therapeutics   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

[N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AMIDO(4 GUANIDO)BUTANE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; DRUG CONFORMATION; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG SPECIFICITY; DRUG SYNTHESIS; ENZYME SPECIFICITY; PROTEINASE INHIBITION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIGENS, DERMATOPHAGOIDES; B-LYMPHOCYTES; CELL LINE; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DRUG DESIGN; FECES; GLYCOPROTEINS; HUMANS; MITES; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; SULFONES; VINYL COMPOUNDS;

EID: 0032080601     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00151-6     Document Type: Article

References (35)

1. 1. The prevalent species found in Europe, including U.K.
2. 2. Voorhoorst, R.; Spieksma, F.T.M.; Varekamp, H.; Leupen, M.J.; J. Allergy, 1967, 39 325.
3. 3. Miyamoto, T.; Oshinia, S.; Ishisaka, T.; Sato, S.; J. Allergy, 1968, 42, 14.
4. 4. Kivity, S.; Solomon, A.; Soferman, R., Schwarz, Y.; Mumcuoglu, K. Y.; Topilsky, M.; J. Allergy Clin. Immunol., 1993, 91, 844.
5. 5. Chapman, M.D.; Rowntree, S.R.; Di Prisco De Fuenmajor, M.S.; Mitchell, E.B.; Plaits-Mills, T.A.E.; J. Allergy Clin. Immunol., 1983, 72, 27.
6. 6. Krillis, S.; Baldo, B. A.; Basten, A.; J. Allergy Clin. Immunol., 1984, 74, 142.
7. 7 Stewart, G.A.; Thompson, P.J.; Simpson, R.J.; Lancet, 1989, July, 15, 154.
8. 8. Lombardero, M.; Heymann, P.W.; Platts-Mill, T.A.E.; Fox, J.W. and Chapman, M.D.; J. Immunol. 1990, 144, 1353.
9. 9. Shultz, O. Laing, P.; Sewell, H.F.; Shakib, F.; Eur. J. Immunol., 1995, 25, 3191.
10. 10. Hewitt, C.R.A.; Brown, A.P.; Hart, B.J.; Pritchard, D.I.; J. Exp. Med 1995, 182, 1537.
11. 11. Shulz, O.; Sutton, B.J.; Beavil, R.L.; Shi, J.; Sewell, H.F.; Gould, H.J.; Laing, P.; Shakib, F. Eur. J. Immunol. 1997, 27, 584.
12. 12. Flores-Romo, L.; Shields, J.; Humbert, Y.; Graber, P; Aubry, J.P.; Gauchet, J.F.; Ayala, G.; Allet, B.; Chavez, M.; Bazin, H.; Capron, M.; Bonnefoy, J.Y.; Science 1993, 261, 1038.
13. 13. Yu, P.; Kosco-Vilbois, M.; Richards, M; Koehler, G.; Lamers, M.C.; Nature 1994, 369, 753.
14. 14. Stief, A.; Texido, G.; Sansig, G.; Eibel, H.; Le Gros, G.; van der Putten, H.; J. Immunol. 1994, 152, 3378.
15. 15. Fujiwara, H.; Kikutani, H.; Suematsu, S.; Naku, T.; Yoshida, K.; Tanaka, T.; Suemura, M.; Matsumoto, N.; Kojima, S.; Kishimoto,. T.; Yoshida, N.; Proc. Natl. Acad. Sci., USA 1994, 91, 6835.
16. 16. Sherr, E.; Macy, E.; Kimata, H.; Gilly, M.; Saxon, A; J. Immunol. 1989, 142, 481.
17. 17. Sarfati, M.; Delespesse, G.; J. Immunol. 1989, 141, 481.
18. 18. Kalsheker, N.A.; Deam, S.; Chambers, L.; Sreedharan, S.; Brocklehurst, K.; Lomas, D.A.; Biochem. Biophys. Res. Commun. 1996, 221, 59.
19. 19. WO 9704004.
20. 20. International Patent application No. PCT/GB97/01158 and PCT/GB97/01157.
21. 21. a)Broemme, D.; Klaus, J.L.; Okamoto, K.; Rasnick, D.; Palmer, J.T.; Biochem. J., 1996, 315, 85.
22. b)Palmer, J.T.; Rasnick, D.; Klaus, J.L.; Broemme, D.; J. Med. Chem., 1995, 38, 3193.
23. 22. Liu, S., Hanzlik, R.P., J. Med. Chem., 1992, 35, 1067.
24. 23. a) Thornberry, N.A. Peterson, E.P., Zhao, J.J., Howard, A.D., Griffen, P.R. and Chapman K.T., Biochemistry 1994, 33, 3934.
25. b) Krantz, A., Copp, L.J. Coles, P.J., Smith R.A. and Heard, S.B. Biochemistry, 1991, 30, 4678.
26. 24. see Wadsworth, W.S. Jr.; Org. React. 1977, 25, 73 and references therein.
27. 25. Fehrentz, J.A.; Castro, B. Synthesis 1983, 676.
28. 26. Nahm, S.; Weinreb, S. Tetrahedron Letters 1981, 22, 3815.
29. nd edition, Springer-Verlag, 1994.
30. 28. The 3 dimensional model of Der p1 was built using "MODELER"™ (MSI, USA) using known x-ray coordinates of papya protease (1ppo.pdb), papain (9pap.pdb) and actinidin (2act.pdb). The sequence alignments and structure refinement were based on the method of Topham et al; Topham, C.M., Srinivasan, N., Thorpe, C.J., Overington, J.P. and Kalsheker, N.A. Protein Engineering 1994, 7, 869.
31. 29. Atherton, E. and Sheppard, R.C., Solid Phase Peptide Synthesis, IRL Press, 1989.
32. 30. Morrison, J.F. & Walsh, C.T.; 1988, Meister, A. (ed.), Adv. Enzymol. Relat. Areas Mol. Biol., 61, 201.
33. 31. Kitz, R. & Wilson, I.B., 1962, J. Biol. Chem.,. 288, 3245.
34. 32. Barrett, A.J., Kembhavi, A.A., Brown, M.A., Kirschke, H., Knight, C.G., Tamai, M., Hanada, K., Biochem. J., 1982, 201, 189.
35. 33. Pliura, D.H.; Bonaventura, R.A.; Smith, R.A.; Coles, P.J.; Krantz, A.; Biochem. J., 1992, 288, 759